Ameloblastoma causes: Difference between revisions
Simrat Sarai (talk | contribs) No edit summary |
Simrat Sarai (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The exact pathogenesis of ameloblastoma is not fully understood. It is thought that ameloblastoma is the result of either suppression of matrix metalloproteinase-2 that may inhibit the local invasiveness of ameloblastoma, or there is also some research suggesting that α5β1 integrin may participate in the local invasiveness of ameloblastomas. | The exact pathogenesis of ameloblastoma is not fully understood. It is thought that ameloblastoma is the result of either suppression of matrix metalloproteinase-2 that may inhibit the local invasiveness of ameloblastoma, or there is also some research suggesting that α5β1 integrin may participate in the local invasiveness of ameloblastomas. | ||
Genes involved in the pathogenesis of ameloblastoma include ''BRAF V600E''. | |||
==Causes== | ==Causes== | ||
There is evidence that suppression of matrix metalloproteinase-2 may inhibit the local invasiveness of ameloblastoma, however, this was only demonstrated in vitro. There is also some research suggesting that α5β1 integrin may participate in the local invasiveness of ameloblastomas. A recent study discovered a high frequency of ''BRAF V600E'' mutations in solid/multicystic ameloblastoma. These data suggests drugs targeting mutant ''BRAF'' as potential novel therapies for ameloblastoma. | There is evidence that suppression of matrix metalloproteinase-2 may inhibit the local invasiveness of ameloblastoma, however, this was only demonstrated in vitro. There is also some research suggesting that α5β1 integrin may participate in the local invasiveness of ameloblastomas. A recent study discovered a high frequency of ''BRAF V600E'' mutations in solid/multicystic ameloblastoma. These data suggests drugs targeting mutant ''BRAF'' as potential novel therapies for ameloblastoma. | ||
Revision as of 20:57, 19 December 2015
|
Ameloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ameloblastoma causes On the Web |
|
American Roentgen Ray Society Images of Ameloblastoma causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
The exact pathogenesis of ameloblastoma is not fully understood. It is thought that ameloblastoma is the result of either suppression of matrix metalloproteinase-2 that may inhibit the local invasiveness of ameloblastoma, or there is also some research suggesting that α5β1 integrin may participate in the local invasiveness of ameloblastomas. Genes involved in the pathogenesis of ameloblastoma include BRAF V600E.
Causes
There is evidence that suppression of matrix metalloproteinase-2 may inhibit the local invasiveness of ameloblastoma, however, this was only demonstrated in vitro. There is also some research suggesting that α5β1 integrin may participate in the local invasiveness of ameloblastomas. A recent study discovered a high frequency of BRAF V600E mutations in solid/multicystic ameloblastoma. These data suggests drugs targeting mutant BRAF as potential novel therapies for ameloblastoma.